Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

US Patent 7785627 · Granted Aug 31, 2010

Estimated economic value: $24,940,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Leuprolide acetate compositions and methods of using the same to treat breast ca2025
Method and compositions for treating dystrophies and myotonia2020
Topiramate compositions and methods of enhancing its bioavailability2017
Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva2015
Controlled release oral dosage form2014
Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva2014
Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva2014
Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva2014
Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva2014
Extended release venlafaxine formulation2014
Oral extended-release composition2014
Controlled release oral dosage form2013